ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
114. Pharmacological chaperone therapy for Gaucher disease: Mechanism of action, a survey of responsive mutations and phase I clinical trial results
Molecular Genetics and Metabolism
◽
10.1016/j.ymgme.2007.10.126
◽
2008
◽
Vol 93
(2)
◽
pp. 44
◽
Cited By ~ 4
Author(s):
Brandon Wustman
◽
Corey Pine
◽
Brian Ranes
◽
John Flanagan
◽
David Palling
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Mechanism Of Action
◽
Gaucher Disease
◽
Phase I Clinical Trial
◽
Disease Mechanism
◽
Pharmacological Chaperone
◽
Clinical Trial Results
Download Full-text
Related Documents
Cited By
References
Phase I clinical trial results of the Envoy System: a totally implantable middle ear device
Otolaryngology
◽
10.1016/s0194-5998(03)01124-0
◽
2003
◽
Vol 129
(2)
◽
pp. P137
Author(s):
D Chen
Keyword(s):
Clinical Trial
◽
Phase I
◽
Middle Ear
◽
Phase I Clinical Trial
◽
System A
◽
Clinical Trial Results
Download Full-text
Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration
British Journal of Ophthalmology
◽
10.1136/bjo.2006.095141
◽
2006
◽
Vol 90
(9)
◽
pp. 1152-1156
◽
Cited By ~ 8
Author(s):
I Kozak
Keyword(s):
Clinical Trial
◽
Phase I
◽
Macular Degeneration
◽
Choroidal Neovascularisation
◽
Phase I Clinical Trial
◽
Age Related Macular Degeneration
◽
Subfoveal Choroidal Neovascularisation
◽
Age Related
◽
Feeder Vessel
◽
Clinical Trial Results
Download Full-text
Abstract CT119: Early phase I clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) plus radiation in cancers involving the CNS
10.1158/1538-7445.am2018-ct119
◽
2018
◽
Author(s):
LR Morgan
◽
T Mahmood
◽
R S. Weiner
◽
R Kawauchi
◽
M Bhandari
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Early Phase
◽
Phase I Clinical Trial
◽
Clinical Trial Results
Download Full-text
Abstract CT101: Phase I clinical trial: results from the use of 4-demethyl-4 cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) plus radiation as treatment for cancers involving the CNS
10.1158/1538-7445.am2020-ct101
◽
2020
◽
Author(s):
Steven J. DiBiase
◽
Roy S. Weiner
◽
Tallat Mahmood
◽
Kendra Harris
◽
Ronald Kawauchi
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Phase I Clinical Trial
◽
Clinical Trial Results
Download Full-text
Phase I Clinical Trial: Results From The Use Of 4-Demethyl-4-Cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) Plus Radiation As Treatment For Cancers Involving The CNS
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2020.07.092
◽
2020
◽
Vol 108
(3)
◽
pp. e716-e717
Author(s):
S.J. DiBiase
◽
R. Weiner
◽
T. Mahmood
◽
K. Harris
◽
A. Baghian
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Phase I Clinical Trial
◽
Clinical Trial Results
Download Full-text
Phase I clinical trial results of aceneuramic acid for GNE myopathy in Japan
Translational Medicine Communications
◽
10.1186/s41231-018-0025-0
◽
2018
◽
Vol 3
(1)
◽
Author(s):
Naoki Suzuki
◽
Masaaki Kato
◽
Hitoshi Warita
◽
Rumiko Izumi
◽
Maki Tateyama
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Phase I Clinical Trial
◽
Gne Myopathy
◽
Clinical Trial Results
Download Full-text
Phase I Clinical Trial of a Genetically Modified and Oncolytic Vaccinia Virus GL-ONC1 in patients with peritoneal carcinomatosis
Zeitschrift für Gastroenterologie
◽
10.1055/s-0032-1324086
◽
2012
◽
Vol 50
(08)
◽
Author(s):
UM Lauer
◽
M Zimmermann
◽
U Koppenhöfer
◽
M Bitzer
◽
NP Malek
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Vaccinia Virus
◽
Peritoneal Carcinomatosis
◽
Genetically Modified
◽
Phase I Clinical Trial
Download Full-text
SAFETY OF A NEW CUBAN PNEUMOCOCCAL CONJUGATE VACCINE: A PHASE I CLINICAL TRIAL IN INFANTS 7 MONTH-OLD
10.26226/morressier.5731f0d7d462b8029237fd99
◽
2016
◽
Author(s):
Rinaldo Puga-Gomez
Keyword(s):
Clinical Trial
◽
Phase I
◽
Conjugate Vaccine
◽
Pneumococcal Conjugate Vaccine
◽
Phase I Clinical Trial
Download Full-text
Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1118816.793494158
◽
2014
◽
Author(s):
Thomas Flaig
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Phase I
◽
Abiraterone Acetate
◽
Selective Inhibitor
◽
Phase I Clinical Trial
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Faculty Opinions recommendation of A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718026292.793481389
◽
2013
◽
Author(s):
Steve Plaxe
◽
Kristy Ward
Keyword(s):
Ovarian Cancer
◽
Clinical Trial
◽
Phase I
◽
Recurrent Ovarian Cancer
◽
Phase I Clinical Trial
◽
Conditionally Replicative Adenovirus
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close